Skip to main content
. 2021 Aug 5;14(8):770. doi: 10.3390/ph14080770

Figure 7.

Figure 7

3D scheme of the ligand–FLT3 receptor interactions. In red, tested molecule (A) catechin, (B) epicatechin, (C) epigallocatechin, (D) gallocatechin, (E) vanillic acid, (F) chlorogenic acid; in black, reference molecule (quizartinib) and labeled amino acid residues interacting with the tested molecule.